FDA approves CSF1R inhibitor for rare, non-cancerous joint tumours

被引：0
|
作者：
Mullard, Asher
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2025年 / 24卷 / 04期
关键词：
D O I：
10.1038/d41573-025-00045-7
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [1] Role of CSF1R Inhibitor Pexidartinib for the Treatment of Cancer
    Russian Journal of Bioorganic Chemistry, 2022, 48 : S1 - S8
  • [2] Role of CSF1R Inhibitor Pexidartinib for the Treatment of Cancer
    Patil, Vaishali M.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2022, 48 (SUPPL 1) : S1 - S8
  • [3] Role of CSF1R 550th-tryptophan in kusunokinin and CSF1R inhibitor binding and ligand-induced structural effect
    Chompunud Na Ayudhya, Chompunud
    Graidist, Potchanapond
    Tipmanee, Varomyalin
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [4] Effect of CSF1R inhibitor on glial cells population and remyelination in the cuprizone model
    Tahmasebi, Fatemeh
    Barati, Shirin
    Kashani, Iraj Ragerdi
    NEUROPEPTIDES, 2021, 89
  • [5] CSF1R Kinase Inhibitor Pexidartinib Disrupts Bile Acid Homeostasis in Mice
    Li, Feng
    Qin, Xuan
    Chen, Si
    Zhou, Shenzhi
    Hakenjos, John M.
    Guo, Lei
    Mackenzie, Kevin R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2025, 392 (03):
  • [6] CSF1R Related Leukoencephalopathy - Rare Childhood Presentation of An Autosomal Dominant Microgliopathy!
    Sriram, Neeharika
    Padmanabha, Hansashree
    Chandra, Sadanandavalli R.
    Mahale, Rohan
    Nandeesh, Bevinahalli
    Bhat, Maya D.
    Christopher, Rita
    Gupta, Manisha
    Udupi, Gautham A.
    Mailankody, Pooja
    Mathuranath, Pavagada S.
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2022, 25 (02) : 311 - +
  • [7] Engineering an inhibitor-resistant human CSF1R variant for microglia replacement
    Chadarevian, Jean Paul
    Lombroso, Sonia I.
    Peet, Graham C.
    Hasselmann, Jonathan
    Tu, Christina
    Marzan, Dave E.
    Capocchi, Joia
    Purnell, Freddy S.
    Nemec, Kelsey M.
    Lahian, Alina
    Escobar, Adrian
    England, Whitney
    Chaluvadi, Sai
    O'Brien, Carleigh A.
    Yaqoob, Fazeela
    Aisenberg, William H.
    Porras-Paniagua, Matias
    Bennett, Mariko L.
    Davtyan, Hayk
    Spitale, Robert C.
    Blurton-Jones, Mathew
    Bennett, F. Chris
    JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 220 (03):
  • [8] Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor–loaded nanoparticle enhances anticancer efficacy
    Anujan Ramesh
    Vaishali Malik
    Hayat Anu Ranjani
    Harriet Smith
    Ashish A. Kulkarni
    Drug Delivery and Translational Research, 2021, 11 : 2317 - 2327
  • [9] An 89Zr-HDL PET Tracer Monitors Response to a CSF1R Inhibitor
    Mason, Christian A.
    Kossatz, Susanne
    Carter, Lukas M.
    Pirovano, Giacomo
    Brand, Christian
    Guru, Navjot
    Perez-Medina, Carlos
    Lewis, Jason S.
    Mulder, Willem J. M.
    Reiner, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (03) : 433 - 436
  • [10] Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor-loaded nanoparticle enhances anticancer efficacy
    Ramesh, Anujan
    Malik, Vaishali
    Ranjani, Hayat Anu
    Smith, Harriet
    Kulkarni, Ashish A.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2021, 11 (06) : 2317 - 2327
12345